Lexington, Mass. – Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced investments in Quanterix’ state-of-the-art Simoa Accelerator Lab services, including the appointment of Dr. Daniel Sikkema, Ph.D., as Vice President of Accelerator Services. Quanterix’ Simoa technology and its growing Accelerator Lab services are enabling biotechnology […]

ST. LOUIS — Canopy BiosciencesTM, LLC, an emerging provider of gene editing and personalized medicine technologies, announced today that it has launched a service for high throughput gene expression analysis.  Based on the NanoString nCounter platform, the service works with a large array of sample types, including formats such as formalin-fixed paraffin-embedded (FFPE), which have been difficult […]

Platform comprises Horizon’s viral, nuclease and transposon gene editing technologies for research and development Three new contract wins contributing a value of more than $2 million in 2017 with potential for long-term alliance development Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), the world leader in the application of gene editing […]

NEWARK, Delaware – CSols, Inc. the premier Laboratory Informatics consultancy, announced the successful completion of the enhancement and extension of GenoLogics Clarity Lab Information Management System (LIMS) for Adaptive Biotechnologies, the leader in high-throughput immunosequencing. To make use of several new features, and to further automate the processing and management of its assays, Adaptive Biotechnologies […]

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has appointed Dr. Madhuri Hegde as vice president and chief scientific officer for its newly created Laboratory Services group within its Diagnostics business.   PerkinElmer’s Laboratory Services group brings together the Company’s global diagnostic lab resources to provide comprehensive genetic screening and diagnostic […]

Goettingen, Germany, Glasgow, UK — Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of a full range of chemistry testing services. Offered by its subsidiary BioOutsource, they characterize the physicochemical properties and structural attributes of therapeutic monoclonal antibodies (mAbs). The service platform methods have been developed to ensure rapid […]

MORGANTOWN, W.Va. and KALAMAZOO, Mich. — Protea Biosciences Group, Inc. (OTCQB: PRGB) (“Protea”) and Proteos, Inc. (“Proteos”) announced today that they have entered into a joint co-marketing agreement.  This mutual partnership allows Protea to combine Proteos’ protein production capabilities alongside Protea’s proprietary bioanalytical services, and allows Proteos to market and promote Protea’s proprietary bioanalytical services with their […]

— Program helps meet customers’ needs for both basic and clinical research applications — Rigorous training ensures consistent and robust results — First genomic service providers certified PLEASANTON, Calif. — Roche (SIX: RO, ROG; OTCQX: RHHBY) is pleased to announce the Certified Service Provider (CSP) program for SeqCap EZ Target Enrichment Systems utilizing Kapa library preparation kits. The program involves […]

Announcing the partnership with B’SYS GmbH to expand SAFETYscan™ in vitro pharmacological profiling services Fremont, CA –– DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, today announced their partnership with B’SYS GmbH to expand DiscoverX’s SAFETYscan in vitro pharmacological profiling services for ion channel assays. SAFETYscan services provide scientists an advanced platform […]